These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6746636)

  • 21. Dopamine D(2) activity of R-(-)-apomorphine and selected analogs: a microdialysis study.
    Rodenhuis N; Dijkstra D; de Boer P; Vermeulen ES; Timmerman W; Wikström HV
    Eur J Pharmacol; 2000 Jan; 387(1):39-45. PubMed ID: 10633158
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aporphines. 48. Enantioselectivity of (R)-(-)- and (S)-(+)-N-n-propylnorapomorphine on dopamine receptors.
    Neumeyer JL; Reischig D; Arana GW; Campbell A; Baldessarini RJ; Kula NS; Watling KJ
    J Med Chem; 1983 Apr; 26(4):516-21. PubMed ID: 6682147
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A new enzyme, NADPH-dihydropteridine reductase in bovine liver.
    Nakanishi N; Hasegawa H; Watabe S
    J Biochem; 1977 Mar; 81(3):681-5. PubMed ID: 16875
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Apomorphine enantiomers' effects on dopamine metabolism: receptor and non-receptor related actions.
    Saller CF; Salama AI
    Eur J Pharmacol; 1986 Feb; 121(2):181-8. PubMed ID: 3699091
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Catalytic properties of NADPH-specific dihydropteridine reductase from bovine liver.
    Nakanishi N; Hasegawa H; Akino M; Yamada S
    J Biochem; 1986 Mar; 99(3):645-52. PubMed ID: 3711040
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Apomorphine does not decrease tissue levels of tetrahydrobiopterin in vivo.
    Bräutigam M; Kittner B; Herken H
    Eur J Pharmacol; 1986 Aug; 127(1-2):143-6. PubMed ID: 3093252
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interaction of a photolabile NADH analog with rat liver dihydropteridine reductase.
    Webber S; Baumgartner K; Blair JN; Whiteley JM
    Biochem Pharmacol; 1988 Jul; 37(14):2869-72. PubMed ID: 3395364
    [No Abstract]   [Full Text] [Related]  

  • 28. Presynaptic dopamine autoreceptors control tyrosine hydroxylase activation in depolarized striatal dopaminergic terminals.
    el Mestikawy S; Glowinski J; Hamon M
    J Neurochem; 1986 Jan; 46(1):12-22. PubMed ID: 2866232
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relative selectivity of 6,7-dihydroxy-2-dimethylaminotetralin, N-n-propyl-3-(3-hydroxyphenyl)piperidine, N-n-propylnorapomorphine and pergolide as agonists at striatal dopamine autoreceptors and postsynaptic dopamine receptors.
    Claustre Y; Fage D; Zivkovic B; Scatton B
    J Pharmacol Exp Ther; 1985 Feb; 232(2):519-25. PubMed ID: 2857197
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is inhibition of striatal synaptosomal tyrosine hydroxylation by dopamine agonists a measure of dopamine autoreceptor function?
    Fowler CJ; Thorell G; Andersson M; Magnusson O
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Oct; 331(1):12-9. PubMed ID: 2866447
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aporphines 65: chemical, microbial synthesis and characterization by gas chromatography/mass spectrometry of (R)-(-)-10-hydroxy 11-methoxy-N-n-propylnoraporphine, a potential metabolite of N-n-propylnorapomorphine.
    Neumeyer JL; Abdel-Maksoud HM; Trainor TM; Vouros P; Davis PJ
    Biomed Environ Mass Spectrom; 1986 May; 13(5):223-9. PubMed ID: 2941089
    [TBL] [Abstract][Full Text] [Related]  

  • 32. N-n-propyl-norapomorphine: an extremely potent stimulant of dopamine autoreceptors.
    Argiolas A; Mereu G; Serra G; Melis MR; Fadda F; Gessa GL
    Brain Res; 1982 Jan; 231(1):109-16. PubMed ID: 6799148
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of specific amino acid modifications on the catalytic properties of rat liver dihydropteridine reductase.
    Webber S; Whiteley JM
    Arch Biochem Biophys; 1981 Jan; 206(1):145-52. PubMed ID: 7212713
    [No Abstract]   [Full Text] [Related]  

  • 34. Dopamine autoreceptor regulation of the kinetic state of striatal tyrosine hydroxylase.
    Strait KA; Kuczenski R
    Mol Pharmacol; 1986 Jun; 29(6):561-9. PubMed ID: 2872588
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of aporphine isomers on rat prolactin.
    Baldessarini RJ; Campbell A; Ben-Jonathan N; Ellingboe J; Zong R; Neumeyer JL
    Neurosci Lett; 1994 Aug; 176(2):269-71. PubMed ID: 7830962
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of striatal tyrosine hydroxylase by low concentrations of apomorphine.
    Laschinski G; Kittner B; Bräutigam M
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Sep; 327(2):114-8. PubMed ID: 6149468
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Steady state kinetics of dihydropteridine reductase: initial velocity and inhibition studies.
    Aksnes A; Ljones T
    Arch Biochem Biophys; 1980 Jul; 202(2):342-7. PubMed ID: 7458324
    [No Abstract]   [Full Text] [Related]  

  • 38. R(-) and S(+) stereoisomers of 11-hydroxy- and 11-methoxy-N-n-propylnoraporphine: central dopaminergic behavioral activity in the rat.
    Campbell A; Baldessarini RJ; Gao Y; Zong R; Neumeyer JL
    Neuropharmacology; 1990 Jun; 29(6):527-36. PubMed ID: 1974710
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Behavioral effects of apomorphine isomers in the rat: selective locomotor-inhibitory effects of S(+)N-n-propylnorapomorphine.
    Campbell A; Baldessarini RJ; Teicher MH; Neumeyer JL
    Psychopharmacology (Berl); 1986; 88(2):158-64. PubMed ID: 3081927
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of human brain dihydropteridine reductase [E.C.1.6.99.10] by the oxidation products of catecholamines, the aminochromes.
    Armarego WL; Waring P
    Biochem Biophys Res Commun; 1983 Jun; 113(3):895-9. PubMed ID: 6870900
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.